BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23662107)

  • 1. Genetic-based biomarkers and next-generation sequencing: the future of personalized care in colorectal cancer.
    Kim RY; Xu H; Myllykangas S; Ji H
    Per Med; 2011 May; 8(3):331-345. PubMed ID: 23662107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical applications of next-generation sequencing in colorectal cancers.
    Kim TM; Lee SH; Chung YJ
    World J Gastroenterol; 2013 Oct; 19(40):6784-93. PubMed ID: 24187453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KRAS Testing for Anti-EGFR Therapy in Advanced Colorectal Cancer: An Evidence-Based and Economic Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(25):1-49. PubMed ID: 23074403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology.
    Cronin M; Ross JS
    Biomark Med; 2011 Jun; 5(3):293-305. PubMed ID: 21657839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current advances in targeted therapy for metastatic colorectal cancer - Clinical translation and future directions.
    Johnson D; Chee CE; Wong W; Lam RCT; Tan IBH; Ma BBY
    Cancer Treat Rev; 2024 Apr; 125():102700. PubMed ID: 38422896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer.
    Morganti S; Tarantino P; Ferraro E; D'Amico P; Duso BA; Curigliano G
    Adv Exp Med Biol; 2019; 1168():9-30. PubMed ID: 31713162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Application of Targeted Next Generation Sequencing for Colorectal Cancers.
    Fontanges Q; De Mendonca R; Salmon I; Le Mercier M; D'Haene N
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
    Wen S; Dai L; Wang L; Wang W; Wu D; Wang K; He Z; Wang A; Chen H; Zhang P; Dong X; Dong YA; Wang K; Yao M; Wang M
    Oncologist; 2019 Nov; 24(11):e1070-e1081. PubMed ID: 30902917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NGS-based oncogenic mutations analysis in advanced colorectal cancer patients improves targeted therapy prediction.
    Li W; Qiu T; Guo L; Ying J; Zhou A
    Pathol Res Pract; 2019 Mar; 215(3):483-489. PubMed ID: 30611619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of amplicon-based next-generation sequencing in cancer.
    Chang F; Li MM
    Cancer Genet; 2013 Dec; 206(12):413-9. PubMed ID: 24332266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translating cancer genomes sequencing revolution into surgical oncology practice.
    Katsios C; Ziogas DE; Liakakos T; Zoras O; Roukos DH
    J Surg Res; 2012 Apr; 173(2):365-9. PubMed ID: 21195428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program.
    Park S; Olsen S; Ku BM; Lee MS; Jung HA; Sun JM; Lee SH; Ahn JS; Park K; Choi YL; Ahn MJ
    Cancer; 2021 Aug; 127(16):3019-3028. PubMed ID: 33826761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-Generation Sequencing and Emerging Technologies.
    Kumar KR; Cowley MJ; Davis RL
    Semin Thromb Hemost; 2019 Oct; 45(7):661-673. PubMed ID: 31096307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
    PĂ©cuchet N; Legras A; Laurent-Puig P; Blons H
    Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole genome sequencing for lung cancer.
    Daniels M; Goh F; Wright CM; Sriram KB; Relan V; Clarke BE; Duhig EE; Bowman RV; Yang IA; Fong KM
    J Thorac Dis; 2012 Apr; 4(2):155-63. PubMed ID: 22833821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-Generation Sequencing and Applications to the Diagnosis and Treatment of Lung Cancer.
    Kruglyak KM; Lin E; Ong FS
    Adv Exp Med Biol; 2016; 890():123-36. PubMed ID: 26703802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Impact of Hybrid Capture-Based Next-Generation Sequencing on Changes in Treatment Decisions in Lung Cancer.
    Rozenblum AB; Ilouze M; Dudnik E; Dvir A; Soussan-Gutman L; Geva S; Peled N
    J Thorac Oncol; 2017 Feb; 12(2):258-268. PubMed ID: 27865871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
    Roukos DH
    Expert Rev Mol Diagn; 2010 Jan; 10(1):33-48. PubMed ID: 20014921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-Generation Sequencing Technology: Current Trends and Advancements.
    Satam H; Joshi K; Mangrolia U; Waghoo S; Zaidi G; Rawool S; Thakare RP; Banday S; Mishra AK; Das G; Malonia SK
    Biology (Basel); 2023 Jul; 12(7):. PubMed ID: 37508427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genome sequencing and personalized medicine: perspectives and limitations].
    Le Gall JY; Debré P;
    Bull Acad Natl Med; 2014 Jan; 198(1):101-17. PubMed ID: 26259290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.